In addition, phosphorylated tau can also be detected in astrocyte glial cells and around the peri-vascular space, lesions often found in post-mortem brains with AD and other tauopathies [14, 33], raising the question of whether SVD differentially impacts tau pathognomonic lesions. The gene discussed is MAPT; the disease is Alzheimer disease.